| 614 |
Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via reduced vascular endothelial growth factor |
You Song |
BY-SA |
227: Activation, PPARα
|
947: Increase, Early Life Stage Mortality
|
|
|
| 615 |
Suppression of Keap1 cysteine oxidation leading to liver inflammation |
Young Jun Kim |
All rights reserved |
2385: Suppression of Keap1 cysteine oxidation
|
902: Inflammation, Liver
|
|
|
| 616 |
organic UV filter and its Photoproducts reproductive toxicity pathways |
Nataraj Bojan |
All rights reserved |
2 MIEs
|
2391: Reduced fertility / fecundity
|
|
|
| 617 |
The adverse outcome pathway of vascular calcification |
Ruiyang Ding |
All rights reserved |
None
|
None
|
|
|
| 618 |
PPARgamma activation leads to a diminished vaccine response |
Léo SPORTES-MILOT |
BY-SA |
1028: Activation of specific nuclear receptors, PPAR-gamma activation
|
2397: Diminished vaccine response
|
|
|
| 619 |
Androgen receptor antagonism leads to delayed preputial seperation via reduced fibroblast growth factor in genital-tubercle tissues |
Travis Karschnik |
BY-SA |
26: Antagonism, Androgen receptor
|
2401: Male preputial separation, failed/delayed
|
|
|
| 620 |
The Adverse Outcome Pathway to Deposition of Energy Leading to Female Decreased Fertility |
Jessica D'Urbano |
All rights reserved |
None
|
None
|
|
|
| 621 |
NOX2 Driven Oxidative Stress-Induced α-Synuclein Radical Formation and Tau Nitration Leading to Neurodegeneration |
Tejasvi kumar |
Open for adoption |
None
|
None
|
|
|
| 631 |
Decreased thyroid hormone receptor beta transcriptional activity leading to MASLD progression via endoplasmic reticulum stress |
You Song |
BY-SA |
None
|
None
|
|
|
| 632 |
Increased adrenal glucocorticoid production leading to MASLD progression (3) |
You Song |
BY-SA |
None
|
None
|
|
|
| 633 |
Increased adrenal glucocorticoid production leading to MASLD progression (4) |
You Song |
BY-SA |
None
|
None
|
|
|
| 634 |
Increased adrenal glucocorticoid production leading to MASLD progression (5) |
You Song |
BY-SA |
None
|
None
|
|
|
| 635 |
Increased adrenal glucocorticoid production leading to MASLD progression (6) |
You Song |
BY-SA |
None
|
None
|
|
|
| 636 |
Increase in reactive oxygen species (ROS) leading to human amyotrophic lateral sclerosis (ALS) |
Shihori Tanabe |
All rights reserved |
1115: Increase, Reactive oxygen species
|
2416: human amyotrophic lateral sclerosis (ALS)
|
|
|
| 637 |
Activation, estrogen receptor alpha leads to increased uterine weight via earlier proliferation of cells of the uterine lining |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2413: Increased, uterine weight
|
|
|
| 638 |
Co-exposure to microplastics and cadmium leading to progression from NAFLD to liver tumorigenesis |
Wei Mu |
BY-SA |
3 MIEs
|
2 AOs
|
|
|
| 639 |
Activation, estrogen receptor alpha leads to precocious puberty via increased kisspeptin release |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2415: Precocious puberty
|
|
|
| 571 |
5α-reductase inhibition leading to hypospadias in male (mammalian) offspring |
Terje Svingen |
BY-SA |
1617: Inhibition, 5α-reductase
|
2082: Hypospadias, increased
|
|
|
| 572 |
BMP4 Suppression Disrupting Cytoskeletal Remodeling Leading to Neural Tube Closure Defects |
Job Berkhout |
BY-SA |
None
|
None
|
|
|
| 573 |
Inhibition, cytochrome oxidase leads to Increased, pulmonary edema |
John Frisch |
BY-SA |
1840: Inhibition, cytochrome oxidase
|
2316: Increased, pulmonary edema
|
|
|
| 574 |
Inhibition, cytochrome oxidase leads to Loss of olfactory function |
John Frisch |
BY-SA |
1840: Inhibition, cytochrome oxidase
|
2317: Loss of olfactory function
|
|
|
| 562 |
HCN Channel Inhibition leading to Arrhythmias |
Young Jun Kim |
BY-SA |
2295: HCN Channel Inhibition
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 563 |
Aryl hydrocarbon Receptor (AHR) activation causes Premature Ovarian Insufficiency via Bax mediated apoptosis |
Sapana Kushwaha |
BY-SA |
18: Activation, AhR
|
2305: Premature ovarian Insufficiency
|
|
|
| 564 |
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity. |
lihua Yang |
BY-SA |
1541: Mitochondrial Complex I inhibition
|
4 AOs
|
|
|
| 565 |
17β-Hydroxysteroid dehydrogenase 2, inhibition leading to activation, estrogen receptor alpha |
Martina Panzarea |
BY-SA |
2250: 17β-Hydroxysteroid dehydrogenase 2, inhibition
|
None
|
|
|